10.30 (0.64%) Sun Pharmaceutical Industries along with its US-based arm Ranbaxy, Inc, has signed a $ 485 million settlement with two plaintiff groups regarding Ranbaxy generic drug application antitrust litigation. The case has been ongoing in the U.S. District Court for the District of Massachusetts (USA) for several years.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.